These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 10052989)

  • 1. Use of "N-in-One" dosing to create an in vivo pharmacokinetics database for use in developing structure-pharmacokinetic relationships.
    Shaffer JE; Adkison KK; Halm K; Hedeen K; Berman J
    J Pharm Sci; 1999 Mar; 88(3):313-8. PubMed ID: 10052989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous pharmacokinetic screening of a mixture of compounds in the dog using API LC/MS/MS analysis for increased throughput.
    Berman J; Halm K; Adkison K; Shaffer J
    J Med Chem; 1997 Mar; 40(6):827-9. PubMed ID: 9083469
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of the cassette dosing approach for assessing the pharmacokinetics of geldanamycin analogues in mice.
    Smith NF; Hayes A; Nutley BP; Raynaud FI; Workman P
    Cancer Chemother Pharmacol; 2004 Dec; 54(6):475-86. PubMed ID: 15526201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of physicochemical and structural properties on the pharmacokinetics of a series of alpha1L-adrenoceptor antagonists.
    Betts A; Atkinson F; Gardner I; Fox D; Webster R; Beaumont K; Morgan P
    Drug Metab Dispos; 2007 Aug; 35(8):1435-45. PubMed ID: 17502340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between pharmacokinetics and blockade of agonist-induced prostatic intraurethral pressure and mean arterial pressure in the conscious dog after single and repeated daily oral administration of terazosin.
    Witte DG; Brune ME; Katwala SP; Milicic I; Kerwin JF; Hancock AA
    J Pharmacol Exp Ther; 1997 Aug; 282(2):891-8. PubMed ID: 9262356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LC fluorescence method for multiple synthetic compounds to rapidly create in vivo pharmacokinetic database utilizing 'N-in-One' dosing.
    Rajanikanth M; Gupta RC
    J Pharm Biomed Anal; 2001 Nov; 26(4):519-30. PubMed ID: 11516902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput analysis in drug discovery: application of liquid chromatography/ion-trap mass spectrometry for simultaneous cassette analysis of alpha-1a antagonists and their metabolites in mouse plasma.
    Cai Z; Han C; Harrelson S; Fung E; Sinhababu AK
    Rapid Commun Mass Spectrom; 2001; 15(8):546-50. PubMed ID: 11312503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Actions of A-131701, a novel, selective antagonist for alpha-1A compared with alpha-1B adrenoceptors on intraurethral and blood pressure responses in conscious dogs and a pharmacodynamic assessment of in vivo prostatic selectivity.
    Hancock AA; Brune ME; Witte DG; Marsh KC; Katwala S; Milicic I; Ireland LM; Crowell D; Meyer MD; Kerwin JF
    J Pharmacol Exp Ther; 1998 May; 285(2):628-42. PubMed ID: 9580607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of a potent and selective alpha 1A antagonist. Utilization of a rapid screening method to obtain pharmacokinetic parameters.
    Adkison KK; Halm KA; Shaffer JE; Drewry D; Sinhababu AK; Berman J
    Pharm Biotechnol; 1998; 11():423-43. PubMed ID: 9760690
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetic theory of cassette dosing in drug discovery screening.
    White RE; Manitpisitkul P
    Drug Metab Dispos; 2001 Jul; 29(7):957-66. PubMed ID: 11408361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cassette dosing pharmacokinetic studies for evaluation of ophthalmic drugs for posterior ocular diseases.
    Proksch JW; Ward KW
    J Pharm Sci; 2008 Aug; 97(8):3411-21. PubMed ID: 17948915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of the site of blood sampling on pharmacokinetic parameters following sublingual dosing to dogs.
    Sohlberg E; Halldin MM; Annas A; Königsson K; Jansson B; Pehrson R; Borg N
    J Pharmacol Toxicol Methods; 2013; 67(1):1-4. PubMed ID: 23138149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer modeling of size and shape descriptors of alpha 1-adrenergic receptor antagonists and quantitative structure-affinity/selectivity relationships.
    Montorsi M; Menziani MC; Cocchi M; Fanelli F; De Benedetti PG
    Methods; 1998 Mar; 14(3):239-54. PubMed ID: 9571081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.
    Nagarathnam D; Wetzel JM; Miao SW; Marzabadi MR; Chiu G; Wong WC; Hong X; Fang J; Forray C; Branchek TA; Heydorn WE; Chang RS; Broten T; Schorn TW; Gluchowski C
    J Med Chem; 1998 Dec; 41(26):5320-33. PubMed ID: 9857099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of automated dried blood spot sampling and LC-MS/MS for pharmacokinetic studies of AMG 517 in rats.
    Uyeda C; Pham R; Fide S; Henne K; Xu G; Soto M; James C; Wong P
    Bioanalysis; 2011 Oct; 3(20):2349-56. PubMed ID: 22011182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of amosulalol, an alpha, beta-adrenoceptor blocker, in rats, dogs and monkeys.
    Kamimura H; Sasaki H; Kawamura S
    Xenobiotica; 1984 Aug; 14(8):613-20. PubMed ID: 6149656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rapid pharmacokinetics screening of drug candidates in vitro and in vivo].
    Dong XN; Zhu XX; Meng ZY; Liu JL; Cao YL; Dou GF
    Yao Xue Xue Bao; 2009 Nov; 44(11):1309-12. PubMed ID: 21355332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonlinear oral pharmacokinetics of the alpha-antagonist 4-amino-5-(4-fluorophenyl)-6,7-dimethoxy-2-[4-(morpholinocarbonyl)-perhydro-1,4-diazepin-1-yl]quinoline in humans: use of preclinical data to rationalize clinical observations.
    Harrison A; Betts A; Fenner K; Beaumont K; Edgington A; Roffey S; Davis J; Comby P; Morgan P
    Drug Metab Dispos; 2004 Feb; 32(2):197-204. PubMed ID: 14744941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and concentration-effect analysis of intravenous RGD891, a platelet GPIIb/IIIa antagonist, using mixed-effects modeling (NONMEM).
    Zannikos PN; Rohatagi S; Jensen BK; DePhillips SL; Rhodes GR
    J Clin Pharmacol; 2000 Oct; 40(10):1129-40. PubMed ID: 11028252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships in 1,4-benzodioxan-related compounds. 6. Role of the dioxane unit on selectivity for alpha(1)-adrenoreceptor subtypes.
    Quaglia W; Pigini M; Piergentili A; Giannella M; Marucci G; Poggesi E; Leonardi A; Melchiorre C
    J Med Chem; 1999 Jul; 42(15):2961-8. PubMed ID: 10425105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.